Remediating chronic axial discogenic back pain Musculoskeletal Diseases
Conditions
Interventions
This is a prospective observational study with 25 treated patients over the age of 21 years old with remediating chronic axial discogenic back pain, where patients will apply the Cetilar Back Pain Sys
Sponsors
PharmaNutra S.p.A.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 21 years old and over 2. Axial back pain from facet degenerative joint disease for more than 3 months
Exclusion criteria
Exclusion criteria: 1. Narcotic pain medication 2. Unwilling to follow study protocol 3. Pregnancy or currently breastfeeding 4. Low back pain from a traumatic injury 5. Currently using a pain patch (e.g lidocaine)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low back symptoms and pain measured using the Roland Morris Disability Questionnaire (RMDQ) pre-supplement and post-supplement after 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures are assessed pre- and post-supplement after 30 days: 1. Pain measured using the Numeric Pain Rating Scale (NPRS) 2. Adverse events measured using patient medical records at the end of the study 3. Treatment failure measured using patient medical records at the end of the study | — |
Countries
United States of America
Contacts
Public ContactAnjali Kashyap
Outcome results
None listed